EQT Fund Management S.a r.l.
Source: SEC Form 13F · as of Mar 2026EQT Fund Management S.a r.l. holds 4 biotech & pharma companies tracked by BioSniper, totaling $420.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
4
Total value held
$420.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Oculis Holding AG (OCS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| OCSOculis Holding AG | 5,900,294 | $156.9M |
| EVMNEvommune, Inc. | 4,929,633 | $113.3M |
| PHVSPharvaris N.V. | 3,424,609 | $96.7M |
| AGMBAgomAb Therapeutics NV | 5,141,992 | $53.9M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.